Skip to main content
. 2021 Apr 29;21:288–302. doi: 10.1016/j.omto.2021.04.010

Figure 4.

Figure 4

The prognostic impact of changes in the immune checkpoint on LGG patients

(A) Kaplan-Meier curves describing the overall survival (OS) for different molecular subtypes. (B) Violin plots demonstrating the differential expression of the immune checkpoint proteins in these subtypes. (C) Kaplan-Meier curves showing the prognostic impact of changes in the immune checkpoint on LGG patients. p values were determined using a Wilcoxon test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗p < 0.0001).